Orthofix to restate past financials on revenue snafu | Wall Street Beat

MassDevice.com Wall Street Beat

Orthofix (NSDQ:OFIX) said an audit of its books is prompting it to restate its financial results for 2011, 2012 and Q1 2013 after discovering revenues that were improperly recognized.

The ongoing review by the Orthofix board of directors’ audit committee means the Lewisville, Texas-based orthopedics company will be late in filing its results for the 2nd quarter, according to regulatory filings.

Orthofix said that "certain revenues recognized during 2011 and 2012, upon further evaluation, should not have been recognized or should not have been recognized during the periods in which they were recognized," according to the filings.

Sign up to get our free newsletters delivered straight to your inbox

"Management continues to assess the company’s disclosure controls and procedures and internal control over financial reporting for current and prior periods. Management does not expect to reach a final conclusion on the effectiveness of the company’s internal control over financial reporting and disclosure controls and procedures until completion of the restatement process, but expects to report in future or amended filings the existence of 1 or more material weaknesses in the company’s internal control over financial reporting relating to the restatement," according to the filings.

Orthofix said it doesn’t know when the audit will be finished or when it expects to release its new financials.

The news sent OFIX shares down 3.2% to $23.09 each as of about 12:45 p.m. today.

 Some hedge funds shed Abiomed, others double down
Hedge fund activity in shares of Abiomed (NSDQ:ABMD)
is down 33%, but some of the remaining hedge investors in the medical device company are increasing their positions in the stock.
Four funds dropped ABMD last quarter, including Broadfin Capital and its $5.4 million stake and Renaissance Technologies’ $3.1 million share. Eight other funds are still in the stock, including Palo Alto Investors ($43.9 million), CR Intrinsic Investors ($14.9 million), Millennium Management, Citadel Investment Group and Adage Capital Management.
Read more

 Mazor Robotics hits the NASDAQ exchange
Mazor Robotics (NSDQ:MZOR) moved to the NASDAQ stock exchange under the "MZOR" symbol, backed by BNY Mellon as depositary bank.
Read more

 InfuSystem is off the auction block
InfuSystem Holdings (NSDQ:INFU) said it’s abandoned a possible sale of the company and named a new chairman, Ryan Morris, who will succeed Wayne Yetter.
Read more

 Artimplant files for bankruptcy
Personal injury lawsuits filed in the U.S. over its CMC Spacer spine implant forced Sweden’s Artimplant to declare bankruptcy.
Read more

 Analysts’ ups and downs

  • Cardinal Health (NYSE:CAH): UBS Investment Research reiterates "buy" rating, raises price target from $53 to $58.
  • Cardiovascular Systems (NSDQ:CSII): Leerink Swann reiterates "outperform" rating, raises price target to $25 from $20.
  • Cutera (NSDQ:CUTR): Piper Jaffray Cos. downgrades from “overweight” to “neutral” rating, lowers price target to $11 from $12; Sidoti downgrades from “buy” to “neutral” rating.
  • Cynosure (NSDQ:CYNO): Citigroup reiterates "buy" rating, raises price target from $36 to $41; Leerink Swann maintains “outperform” rating, ~$36 valuation
  • Dentsply International (NSDQ:XRAY): Northcoast Research downgrades from “buy” to “neutral” rating.
  • Endo Health Solutions (NSDQ:ENDP): UBS raises estimates, boosts price target to $43 from $41.
  • Fresenius (NYSE:FMS): Societe Generale downgrades from “buy” to “hold” rating.
  • GE (NYSE:GE): TheStreet reiterates “buy” rating.
  • Globus Medical (NYSE:GMED): Leerink Swann reiterates “outperform” rating, raises price target to $21 from $19.
  • Hanger (NYSE:HGR): CJS Securities downgrades from “outperform” to “market perform” rating, $35 price target.
  • Hologic (NSDQ:HOLX): Leerink Swann maintains “outperform” rating, lowers price target to $26 from $27.
  • Hospira (NYSE:HSP): Leerink Swann maintains “market perform” rating, raises price target from $32-$33 to $43
  • ICU Medical (NSDQ:ICUI): Raymond James downgrades from “outperform” to “market perform” rating.
  • ResMed (NYSE:RMD): Deutsche Bank upgrades from “hold” to “buy” rating, raises price target to 83¢ from 71¢.
  • RTI Surgical (NSDQ:RTIX): Canaccord Genuity downgrades from "buy" to "hold" rating, lowers price target from $5 to $3.50.
  • Siemens (NYSE:SI): Zacks downgrades from “neutral” to “underperform” rating, $101 price target.
  • Sirona Dental Systems (NSDQ:SIRO): Barrington Research upgrades from “market perform” to “outperform” rating, $82 price target.
  • SurModics (NSDQ:SRDX): Feltl & Co. upgrades from “buy” to “strong-buy” rating, $31.25 price target.
  • Teleflex (NYSE:TFX): Leerink Swann maintains “market perform” rating, $85 price target.
  • Thoratec (NSDQ:THOR): Northland Capital Partners upgrades from “market perform” to “outperform” rating, raises price target to $42 from $35.
  • Volcano (NSDQ:VOLC): Canaccord Genuity upgrades from “hold” to “buy” rating, raises price target from $21 to $26; Leerink Swann maintains “outperform” rating, $25 price target.
  • Wright Medical (NSDQ:WMGI): Leerink Swann maintains “outperform” rating, increases price target to $32 from $29.

RSS From Medical Design & Outsourcing

  • Teknor Apex to showcase wide range of PVC compounds for medical devices at Medtec China
    Building on its international leadership role as a supplier of medical-grade PVC compounds, Teknor Apex Company has developed flexible and rigid formulations that address the special needs of device manufacturers. The company will highlight these capabilities at Medtec China 2015. “Teknor Apex produces or markets medical-grade PVC compounds in China, Singapore, Europe, and the United […]
  • The Raspberry Pi eco-system goes interstellar with the new Raspberry Pi Sense HAT
    Newark element14 has globally launched the latest addition to the expanding ecosystem of Raspberry Pi accessories, the Raspberry Pi Sense HAT, as featured in the ‘Astro Pi’ space mission. The Sense HAT will enable enthusiasts to control the same hardware used in space. The Sense HAT attaches to the Raspberry Pi board, and can be […]
  • CommScope completes acquisition of TE Connectivity’s Telecom
    CommScope Holding Company, has completed its previously announced acquisition of TE Connectivity’s Telecom, Enterprise and Wireless businesses, a leader in fiber optic connectivity for wireline and wireless networks. The all-cash transaction, valued at approximately $3 billion, strengthens CommScope’s position as a leading communications infrastructure provider with deeper resources to meet the world’s growing demand for network […]
  • SPI awards IKO Prosthetic Creative System the Student Design International Design Excellence Award
    SPI: The Plastics Industry Trade Association congratulated IKO Prosthetic Creative System for winning the SPI Student Design Award, part of the Industrial Designers Society of America’s (IDSA’s) International Design Excellence Awards (IDEA) program. The award was presented to IKO, an innovative, youth-focused prosthetic design company led by Chicago-based designer Carlos Torres, by SPI’s Senior Director of […]
  • New assay could revolutionize diagnosis and treatment of life-threatening disease
    Invasive Fungal Disease (IFD) is an emerging global health problem associated with high mortality rates in severely immunocompromised patients, such as those undergoing intensive chemotherapy or stem cell transplantation, and in patients suffering immune compromising conditions such as AIDS. The most common causative agents of this disease have been identified as Candida and Aspergillus species, […]
  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]

Leave a Reply